The novel coronavirus continues to make headlines all over the place these days, and this is a trend that seems to continue. Check out the latest reports below.
AstraZeneca covid vaccine in the news
There is a new study that reportedly found a causal link between the viral vector vaccines by AstraZeneca and Johnson & Johnson and the occurrence of blood disorders.
It seems that the controversy around the covid vaccine continues.
A recent study conducted by the British Medical Journal found that the risk of thrombosis -(this means blood clots that block blood vessels) after an AstraZeneca vaccine was higher than after a Pfizer/BioNTech vaccine.
“After a first dose of the AstraZeneca vaccine, there is a 30% higher risk of thrombocytopenia compared to a first dose of the Pfizer vaccine,” the study noted. The very same notes also added that this risk is rare.
It’s also important to mention the fact that their frequency remains very low (with 862 cases for more than one million people vaccinated), and the study confirmed that these thromboses are more common after the AstraZeneca vaccine.
It’s been revealed that the thrombosis risk increased after the first dose; the study found no differences between the AstraZeneca and Pfizer vaccines after the second dose. We suggest that you check out the original article in order to learn more reports about this.
New covid variants spread terror
According to the latest reports, a few months ago, all eyes were on the strain called “Deltacron.” This was a frankenvirus, of sorts, that combined Delta and Omicron, and potentially the worst traits of both.
The initial strain, reported in January, failed to take flight. Reports of additional Delta-Omicron hybrids in multiple locations across the globe later emerged, then fizzled.
But at the end of 2022, the Deltacron phenomenon is back, and this time it’s in the form of new Covid variants XBC, XAY, and XAW. Check out the previous article that we shared to learn more details about this.